C000220939 Performance — BlackRock LifePath ESG Index 2030 Fund, Investor A
Data updated: 2026-09-25
C000220939 returned +5.62% year to date and +12.28% over one year to Jul 2026. Annualised returns are +10.62% over 3 years and +5.00% over 5 years. The fund trailed its Target-Date category average: $100 invested three years ago grew to $135, against $146 for the category, and to $112 over one year, against $116. Volatility over the past three years was 8.57% a year. In the 12 months to Jul 2026 the fund took in a net $3.0M, and assets reached $15.79M.
C000220939 Growth of $100
What $100 invested in BlackRock LifePath ESG Index 2030 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | C000220939 | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $112 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $135 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $128 | $142 |
| Since data start (Aug 2020 – Jul 2026) | $152 | $174 |
C000220939 Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.62% |
| 1 year | +12.28% |
| 3 years (annualised) | +10.62% |
| 5 years (annualised) | +5.00% |
C000220939 Annual Returns
Calendar-year total returns of BlackRock LifePath ESG Index 2030 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +5.62% |
| 2025 | +13.83% |
| 2024 | +8.73% |
| 2023 | +14.33% |
| 2022 | −16.63% |
| 2021 | +11.58% |
| 2020 (Aug–Dec) | +9.12% |
C000220939 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.7% | +1.6% | −4.1% | +4.9% | +2.4% | 0.0% | −0.8% | — | — | — | — | — |
| 2025 | +1.9% | +0.6% | −1.9% | +0.3% | +2.8% | +3.1% | +0.2% | +2.1% | +2.2% | +1.3% | +0.3% | +0.3% |
| 2024 | −0.3% | +1.7% | +2.2% | −3.0% | +3.0% | +1.3% | +2.3% | +1.9% | +1.9% | −2.6% | +2.7% | −2.5% |
| 2023 | +5.9% | −2.8% | +2.4% | +0.9% | −1.4% | +3.1% | +2.1% | −1.9% | −3.4% | −2.4% | +7.1% | +4.6% |
| 2022 | −4.1% | −2.1% | +0.2% | −6.3% | +0.3% | −5.9% | +5.7% | −3.9% | −7.7% | +3.6% | +6.2% | −3.0% |
| 2021 | −0.3% | +1.2% | +1.6% | +2.9% | +1.2% | +0.9% | +1.1% | +1.4% | −2.9% | +3.3% | −1.7% | +2.5% |
| 2020 | — | — | — | — | — | — | — | +1.1% | −2.1% | −1.6% | +8.6% | +3.2% |
C000220939 Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 8.57%
- 3-year Sharpe ratio: 0.71 (vs 4.5% risk-free rate)
- Best month: +7.06% (Nov 2023)
- Worst month: −4.11% (Mar 2026)
C000220939 Fund Flows
Monthly money in and out of BlackRock LifePath ESG Index 2030 Fund, from SEC Form N-PORT.
- 12-month net flow: $3.0M
- 12-month gross sales (incl. reinvestments): $6.4M
- Sales ÷ redemptions: 1.87×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $100K | $1.8M | −$1.7M |
| Jun 2026 | $262K | $204K | $58K |
| May 2026 | $189K | $191K | −$1K |
| Apr 2026 | $894K | $145K | $749K |
| Mar 2026 | $291K | $74K | $217K |
| Feb 2026 | $84K | $429K | −$345K |
| Jan 2026 | $320K | $55K | $265K |
| Dec 2025 | $447K | $15K | $432K |
| Nov 2025 | $66K | $325K | −$259K |
| Oct 2025 | $348K | $44K | $304K |
| Sep 2025 | $1.4M | $11K | $1.3M |
| Aug 2025 | $2.0M | $112K | $1.9M |
C000220939 Assets Under Management
Net assets of BlackRock LifePath ESG Index 2030 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $15.79M |
| 2026-04-30 | $17.16M |
| 2026-01-31 | $16.15M |
| 2025-10-31 | $15.69M |
| 2025-07-31 | $11.33M |
| 2025-04-30 | $6.31M |
| 2025-01-31 | $6.02M |
| 2024-10-31 | $5.99M |
| 2024-07-31 | $6.51M |
| 2024-04-30 | $4.15M |
| 2024-01-31 | $5.97M |
| 2023-10-31 | $5.27M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.